The Metabolomic Quest for a Biomarker in Chronic Kidney Disease

Overview

Journal Clin Kidney J

Publisher Oxford University Press

Specialty Nephrology

Date 2018 Oct 6

PMID 30288265

Citations 21

Authors

Robert Davies

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease (CKD) is a growing burden on people and on healthcare for which the diagnostics are niether disease-specific nor indicative of progression. Biomarkers are sought to enable clinicians to offer more appropriate patient-centred treatments, which could come to fruition by using a metabolomics approach. This mini-review highlights the current literature of metabolomics and CKD, and suggests additional factors that need to be considered in this quest for a biomarker, namely the diet and the gut microbiome, for more meaningful advances to be made.

Citing Articles

Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine.

Delrue C, Speeckaert M J Pers Med. 2024; 14(12).

PMID: 39728069 PMC: 11679258. DOI: 10.3390/jpm14121157.

Steps to understanding diabetes kidney disease: a focus on metabolomics.

Kim H, Song S Korean J Intern Med. 2024; 39(6):898-905.

PMID: 39434603 PMC: 11569920. DOI: 10.3904/kjim.2024.111.

Exposome and Metabolome Analysis of Sugarcane Workers Reveals Predictors of Kidney Injury.

Stem A, Brindley S, Rogers K, Salih A, Roncal-Jimenez C, Johnson R Kidney Int Rep. 2024; 9(5):1458-1472.

PMID: 38707825 PMC: 11069010. DOI: 10.1016/j.ekir.2024.01.060.

Metabolome panels as potential noninvasive biomarkers for primary glomerulonephritis sub-types: meta-analysis of profiling metabolomics studies.

Roointan A, Ghaeidamini M, Shafieizadegan S, Hudkins K, Gholaminejad A Sci Rep. 2023; 13(1):20325.

PMID: 37990116 PMC: 10663527. DOI: 10.1038/s41598-023-47800-7.

Exploration of Potential Breath Biomarkers of Chronic Kidney Disease through Thermal Desorption-Gas Chromatography/Mass Spectrometry.

Seong S, Kim H, Lee Y, Kim J, Park S, Oh J Metabolites. 2023; 13(7).

PMID: 37512544 PMC: 10385797. DOI: 10.3390/metabo13070837.

References

Zhang Z, Mao J, Chen H, Su W, Zhang Y, Zhang L . Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites. Clin Biochem. 2017; 50(18):1078-1086. DOI: 10.1016/j.clinbiochem.2017.09.012. View

Ramautar R, Somsen G, de Jong G . CE-MS for metabolomics: Developments and applications in the period 2014-2016. Electrophoresis. 2016; 38(1):190-202. PMC: 5248609. DOI: 10.1002/elps.201600370. View

Shirazian S, Grant C, Aina O, Mattana J, Khorassani F, Ricardo A . Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management. Kidney Int Rep. 2018; 2(1):94-107. PMC: 5720531. DOI: 10.1016/j.ekir.2016.09.005. View

Everett J . A new paradigm for known metabolite identification in metabonomics/metabolomics: metabolite identification efficiency. Comput Struct Biotechnol J. 2015; 13:131-44. PMC: 4348432. DOI: 10.1016/j.csbj.2015.01.002. View

Magalhaes L, Dos Reis L, Graciolli F, Pereira B, de Oliveira R, de Souza A . Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start Hemodialysis. PLoS One. 2017; 12(1):e0167895. PMC: 5207446. DOI: 10.1371/journal.pone.0167895. View

Meier R, Ruttkies C, Treutler H, Neumann S . Bioinformatics can boost metabolomics research. J Biotechnol. 2017; 261:137-141. DOI: 10.1016/j.jbiotec.2017.05.018. View

Wishart D . Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016; 15(7):473-84. DOI: 10.1038/nrd.2016.32. View

Suhre K, Shin S, Petersen A, Mohney R, Meredith D, Wagele B . Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011; 477(7362):54-60. PMC: 3832838. DOI: 10.1038/nature10354. View

Emwas A, Roy R, McKay R, Ryan D, Brennan L, Tenori L . Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis. J Proteome Res. 2016; 15(2):360-73. PMC: 4865177. DOI: 10.1021/acs.jproteome.5b00885. View

10.

Chaleckis R, Murakami I, Takada J, Kondoh H, Yanagida M . Individual variability in human blood metabolites identifies age-related differences. Proc Natl Acad Sci U S A. 2016; 113(16):4252-9. PMC: 4843419. DOI: 10.1073/pnas.1603023113. View

11.

Yin P, Lehmann R, Xu G . Effects of pre-analytical processes on blood samples used in metabolomics studies. Anal Bioanal Chem. 2015; 407(17):4879-92. PMC: 4471316. DOI: 10.1007/s00216-015-8565-x. View

12.

Holen T, Norheim F, Gundersen T, Mitry P, Linseisen J, Iversen P . Biomarkers for nutrient intake with focus on alternative sampling techniques. Genes Nutr. 2016; 11:12. PMC: 4968438. DOI: 10.1186/s12263-016-0527-1. View

13.

Kurella Tamura M, Meyer J, Saxena A, Huh J, Wadley V, Schiller B . Prevalence and significance of stroke symptoms among patients receiving maintenance dialysis. Neurology. 2012; 79(10):981-7. PMC: 3430712. DOI: 10.1212/WNL.0b013e31826845e9. View

14.

Niewczas M, Mathew A, Croall S, Byun J, Major M, Sabisetti V . Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care. 2017; 40(3):383-390. PMC: 5319475. DOI: 10.2337/dc16-0173. View

15.

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

16.

Mendes-Soares H, Chia N . Community metabolic modeling approaches to understanding the gut microbiome: Bridging biochemistry and ecology. Free Radic Biol Med. 2016; 105:102-109. PMC: 5401773. DOI: 10.1016/j.freeradbiomed.2016.12.017. View

17.

Raffler J, Friedrich N, Arnold M, Kacprowski T, Rueedi R, Altmaier E . Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality. PLoS Genet. 2015; 11(9):e1005487. PMC: 4564198. DOI: 10.1371/journal.pgen.1005487. View

18.

Piccoli G, Vigotti F, Leone F, Capizzi I, Daidola G, Cabiddu G . Low-protein diets in CKD: how can we achieve them? A narrative, pragmatic review. Clin Kidney J. 2015; 8(1):61-70. PMC: 4310428. DOI: 10.1093/ckj/sfu125. View

19.

Jobard E, Tredan O, Postoly D, Andre F, Martin A, Elena-Herrmann B . A Systematic Evaluation of Blood Serum and Plasma Pre-Analytics for Metabolomics Cohort Studies. Int J Mol Sci. 2016; 17(12). PMC: 5187835. DOI: 10.3390/ijms17122035. View

20.

Hocher B, Adamski J . Metabolomics for clinical use and research in chronic kidney disease. Nat Rev Nephrol. 2017; 13(5):269-284. DOI: 10.1038/nrneph.2017.30. View